Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | ACP3 | P15309 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5306707 | 0.88 | CYP2D6 (0.52) | CYP2D6SMN1; SMN2CYP1A2PKMNPSR1 | |
| SCHEMBL6176608 | 0.86 | KMT2A (0.47) | CYP2D6SMN1; SMN2CYP1A2PKMNPSR1 | |
| SCHEMBL286685 | 0.84 | KMT2A (0.48) | CYP2D6KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL986067 | 0.84 | KMT2A (0.48) | CYP2D6KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL27679472 | 0.83 | ALDH1A1 (0.54) | CYP2D6SMN1; SMN2CYP1A2PKMNPSR1 | |
| SCHEMBL10827238 | 0.82 | KMT2A (0.47) | CYP2D6PKMKMT2AALDH1A1LMNA | |
| SCHEMBL1030015 | 0.82 | ALDH1A1 (0.53) | CYP2D6KMT2AALDH1A1LMNACYP3A4 | |
| SCHEMBL7815599 | 0.81 | KMT2A (0.50) | CYP2D6CYP1A2PKMNPSR1KMT2A | |
| SCHEMBL9118007 | 0.80 | CTSD (0.46) | CYP2D6SMN1; SMN2CYP1A2KMT2AALDH1A1 | |
| SCHEMBL11477715 | 0.80 | HCAR2 (0.40) | CYP2D6SMN1; SMN2CYP1A2PKMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538510-A1 | PROCESS FOR THE PREPARATION OF MONO-PROTECTED alpha,omega-DIAMINO ALKANES | Synthon Biopharmaceuticals B.V. (NL) | 2019-09-18 | — | — | EP | claimed |
| WO-2018086993-A1 | PROCESS FOR THE PREPARATION OF MONO-PROTECTED alpha,omega-DIAMINO ALKANES | SYNTHON BIOPHARMACEUTICALS B.V. (NL) | 2018-05-17 | — | — | WO | claimed |
| EP-4590663-A2 | SYNTHESIS OF CYCLOPROPANE CARBOXYLIC ACIDS | Takeda Pharmaceutical Company Limited (JP) | 2025-07-30 | — | — | EP | disclosed |
| WO-2025151874-A1 | INDOLE ALKALOID ANTIPLASMODIAL AGENTS AND PREPARATION THEREOF | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) | 2025-07-17 | — | — | WO | disclosed |
| US-12083186-B2 | Methods for assembling scavenging particles | NANOTICS, LLC (US) | 2024-09-10 | — | — | US | disclosed |
| US-20240269319-A1 | METHODS FOR ASSEMBLING SCAVENGING PARTICLES | NANOTICS, LLC | 2024-08-15 | — | — | US | disclosed |
| WO-2024147060-A1 | NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY | CELON PHARMA S.A. (PL) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024145435-A2 | LIPID COMPOSITIONS AND METHODS FOR DELIVERY TO IMMUNE CELLS | Life Technologies Corporation (US) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024133853-A1 | BIS-ESTER AND AMIDE CATIONIC LIPIDS | SANOFI (FR) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024130217-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024130218-A1 | STAPLED PEPTIDES AND METHODS THEREOF | FOG PHARMACEUTICALS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| US-20050054020-A1 | Protein O-sulfonation | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2005-03-10 | — | — | US | disclosed |
| WO-2005001047-A2 | N-CARBOBENZYLOXY (N-CBZ)-DEPROTECTING ENZYME AND USES THEREFOR | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004056970-A2 | CHEMO-ENZYMATIC PROCESS FOR PROTEOME-WIDE MAPPING OF POST-TRANSLATIONAL MODIFICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-07-08 | — | — | WO | disclosed |
| EP-1348025-A2 | ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES | Bristol-Myers Squibb Company (US) | 2003-10-01 | — | — | EP | disclosed |
| WO-2002053724-A2 | ENZYMATIC DEPROTECTION OF AMINES AND HYDROXIDES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-07-11 | — | — | WO | disclosed |
| CN-1247535-A | Aminoepoxides from aminoaldehydes and in-situ formed halomethyl organometallic reagent | SEARLE & CO (US) | 2000-03-15 | — | — | CN | disclosed |
| WO-1997049723-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACID TO CELLS | GILEAD SCIENCES, INC. (US) | 1997-12-31 | — | — | WO | disclosed |
| WO-1996001841-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS | GILEAD SCIENCES, INC. (US) | 1996-01-25 | — | — | WO | disclosed |
| WO-1996001840-A1 | CATIONIC LIPIDS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS | GILEAD SCIENCES, INC. (US) | 1996-01-25 | — | — | WO | disclosed |